McKesson (MCK) DIvidends Date & History

Key Takeaways

• MCK currently offers a modest dividend yield of roughly 0.4%, well below the broader healthcare sector average.
• The company pays a quarterly dividend, most recently increased to $0.94 per share.
• McKesson has raised its dividend for roughly 17 consecutive years, with a five-year compound growth rate of about 13%.
• The dividend payout ratio is exceptionally low, around 9% to 10% of earnings, leaving ample room for future increases.
• The stock is better suited to dividend growth investors than to income-focused investors seeking high current yield.

Dividend Overview

McKesson Corporation is a leading pharmaceutical distribution and healthcare services company that has maintained a consistent, well-covered quarterly dividend for decades. As of late 2026, MCK pays an annualized dividend of approximately $3.76 per share, translating to a dividend yield of roughly 0.43%. The dividend is paid every quarter, and the company has demonstrated a clear pattern of annual increases. Rather than functioning as a high-yield income vehicle, McKesson is best classified as a dividend growth stock: its yield is intentionally low relative to income-oriented names, but the company has prioritized steady, above-average dividend growth while supplementing shareholder returns with substantial share buybacks. This profile tends to appeal to investors who value long-term dividend compounding over immediate income.

Dividend History and Growth

McKesson has built an extended track record of dividend reliability, having increased its payout for roughly 17 consecutive years. Over the past five years, the dividend has grown at a compound annual rate of approximately 13%, and the pace of recent increases has been even stronger. The quarterly payout climbed from $0.62 per share in 2024 to $0.71 in early 2025, then to $0.82 later that year, and most recently to $0.94 per share following a July 2026 declaration. This consistent, mid-teens percentage growth reflects management's confidence in the company's cash-generating ability. While the headline yield remains small, the growth trajectory means the dividend per share has more than doubled over a relatively short horizon, underscoring McKesson's commitment to returning capital to shareholders on a disciplined, escalating basis.

Dividend Sustainability and Payout Ratio

McKesson's dividend is among the most conservatively funded in the market. The payout ratio, which measures dividends as a percentage of earnings per share (EPS), stands at roughly 9% to 10% on a trailing twelve-month basis. This is a very low figure by almost any standard, indicating the company distributes only a small fraction of its profits to shareholders while retaining the vast majority for reinvestment, debt reduction, and share repurchases. The free cash flow (FCF) coverage is similarly comfortable, with dividend payments representing a single-digit percentage of cash flow. McKesson's large-scale, relatively stable distribution business generates consistent cash, and its financial position is solid. These factors together suggest the dividend is highly sustainable and that the company retains significant flexibility to continue raising the payout even in the event of an earnings slowdown.

Dividend Compared to Industry Peers

Within the healthcare distribution and services industry, McKesson's dividend yield is on the lower end of the spectrum. Its roughly 0.4% yield is meaningfully below the healthcare sector average of about 1.4% and below the industry median of roughly 2% to 2.5%. Peer distributors such as Cencora (COR) and Cardinal Health (CAH) generally offer higher current yields. However, McKesson offsets its low yield with a faster dividend growth rate and a more aggressive share buyback program, which together produce a competitive total shareholder return. For investors, the key trade-off is clear: McKesson prioritizes dividend growth and capital returns over a high starting income yield, whereas several peers deliver more income today but with comparatively slower payout expansion.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener is particularly useful for identifying dividend stocks, income-focused investments, breakout candidates, and trending opportunities far more efficiently than manual screening. If you are evaluating dividend-paying names like McKesson or comparing them across the healthcare sector, the AI Screener can help you surface and prioritize candidates that match your specific income or growth criteria.

Is This Stock Attractive for Dividend Investors?

McKesson is likely to appeal most to dividend growth investors and long-term, total-return-oriented investors rather than to those who require substantial current income. With a yield below 0.5%, the stock is not a natural fit for income-focused investors or retirees relying on dividend payments for near-term cash flow. Instead, its attractiveness lies in the combination of a low and highly secure payout ratio, roughly 17 consecutive years of dividend increases, and a double-digit dividend growth rate. Investors with a long time horizon may value the prospect of compounding growth on a modest starting yield. That said, the modest yield means the stock's dividend appeal depends heavily on future growth and broader share-price appreciation, making it better suited to investors who can accept a lower income stream today in exchange for potential payout growth over time.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations